Burkehill Global Management »

Immix Biopharma shares owned by Burkehill Global Management

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Burkehill Global Management from 13F filings

Historical chart of Burkehill Global Management investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Burkehill Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Burkehill Global Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5M 294k 5.23

More positions owned by Burkehill Global Management

Itt (ITT)
Sofi Technologies (SOFI)
Nasdaq Omx (NDAQ)
Lauder Estee Cos Cl A (EL)
Coreweave Com Cl A (CRWV)
Rollins (ROL)
Standardaero (SARO)
Medline Com Cl A (MDLN)
Realty Income (O)
Galaxy Digital Cl A (GLXY)
Figure Technology Solutio Com Cl A (FIGR)
Viking Holdings Ord Shs (VIK)
Symbotic Class A Com (SYM)
Nebius Group Shs Class A (NBIS)
Loar Holdings Com Shs (LOAR)

View all positions for Burkehill Global Management

Top funds holding Immix Biopharma

Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Vanguard Group
Logos Global Management
Bleichroeder
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
Ameriprise Financial
Burkehill Global Management
Renaissance Technologies
Geode Capital Management
KVP Capital Advisors
Goldman Sachs Group

View all funds holding Immix Biopharma